182 results
8-K
EX-10.1
INVA
Innoviva Inc
25 Aug 23
Innoviva Appoints Stephen Basso as Chief Financial Officer
5:24pm
rights. The employer or the employee may disclose such inventions to the department of employment security, and the department shall maintain a record of such disclosures for a minimum period of five years.
iv
8-K
INVA
Innoviva Inc
7 Aug 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:42pm
Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, due to Dr. Deborah L. Birx’s previously disclosed
SC TO-T
EX-99
r39lzok2weff
25 Jul 22
Third party tender offer statement
8:34am
SC TO-T
EX-99
yqyca8w32
25 Jul 22
Third party tender offer statement
8:34am
8-K
EX-10.1
zr434 15ga
13 Jul 22
Entry into a Material Definitive Agreement
5:27pm
SC TO-C
EX-2.1
vbfjdr kr1
11 Jul 22
Information about tender offer
3:46pm
8-K
EX-2.1
r19nec
11 Jul 22
Innoviva to Acquire La Jolla Pharmaceutical Company
7:38am
425
q0g 6popooeyq
11 Jul 22
Business combination disclosure
7:38am
SC TO-T
EX-99
n5u ca8v6h
7 Jun 22
Third party tender offer statement
9:04am
SC TO-C
EX-2.1
0x5 5qm02lb
23 May 22
Information about tender offer
8:53pm
8-K
EX-2.1
rl6w6ftoywq334
23 May 22
Tender and Support Agreement
8:51pm
8-K
EX-4.1
33vbqn 9k0ho2ah0qx
8 Mar 22
Innoviva Announces Proposed Offering of $200 Million of Convertible Senior Notes
5:15pm
8-K
EX-10.1
wxj22jexm7as
8 Mar 22
Innoviva Announces Proposed Offering of $200 Million of Convertible Senior Notes
5:15pm